Fontaine progeroid syndrome-A case report

Sinéad Lally1, Nicola Walsh2, Janna Kenny2

  • 1Department of Paediatrics Cavan Monaghan Hospital, RCSI Hospital Group Cavan Ireland.

Clinical Case Reports
|September 12, 2022
PubMed

Insights

Fontaine progeroid syndrome (FPS) is a rare genetic disorder caused by SLC25A24 gene mutations. This report details the clinical journey of an infant patient with FPS, highlighting the condition's severe progression and early fatality.

Area of Science:

  • Genetics
  • Molecular Biology
  • Pediatrics

Background:

  • Fontaine progeroid syndrome (FPS) is an autosomal dominant disorder.
  • Pathogenic variants in the SLC25A24 gene are identified as the cause of FPS.
  • Limited case studies exist, with some reporting early lethality.

Observation:

  • This study presents the comprehensive clinical course of a single patient diagnosed with Fontaine progeroid syndrome.
  • The patient's condition was monitored from birth until 7 months of age.
  • Detailed clinical observations throughout the patient's brief lifespan are discussed.

Findings:

  • The case illustrates the severe phenotype associated with Fontaine progeroid syndrome.
  • Early lethality was observed in this patient, consistent with some literature reports.
  • The SLC25A24 gene variants contribute to a rapidly progressive and fatal condition.

Implications:

  • This case contributes to the limited understanding of Fontaine progeroid syndrome.
  • Further research into SLC25A24 gene function is warranted.
  • Understanding FPS progression can aid in supportive care and future therapeutic strategies.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
345
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
21
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
214